Vireo Growth (VREOF) Cash from Financing Activities (2020 - 2026)

Vireo Growth's (VREOF) quarterly Cash from Financing Activities came in at -$4.6 million in Q1 2026, down 411.11% year-on-year from $1.5 million in Q1 2025, and down 7.52% quarter-over-quarter from -$4.3 million in Q4 2025.

Vireo Growth (VREOF) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Cash from Financing Activities across 7 years of filings, most recently posting -$4.6 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$4.6 million, down 411.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.7 million (down 84.38% YoY), and the FY2025 annual result was $18.4 million, down 80.41% from the prior year.
  • Cash from Financing Activities came in at -$4.6 million for Q1 2026 at Vireo Growth, down from -$4.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $93.4 million in Q4 2024 to a low of -$9.3 million in Q2 2025.
  • The 5-year median for Cash from Financing Activities is $821721.0 (2023), against an average of $8.0 million.
  • Peak annual rise in Cash from Financing Activities reached 45862.26% in 2025, while the deepest fall reached 609.87% in 2025.
  • Vireo Growth's Cash from Financing Activities stood at $245839.0 in 2022, then surged by 1242.04% to $3.3 million in 2023, then soared by 2730.21% to $93.4 million in 2024, then plunged by 104.58% to -$4.3 million in 2025, then slipped by 7.52% to -$4.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$4.6 million (Q1 2026), -$4.3 million (Q4 2025), and $32.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Vireo Growth - - 59.30 Mn -4.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.60 Mn
Mar 31, 2026 -4.60 Mn
Dec 31, 2025 -4.28 Mn
Dec 31, 2025 -4.28 Mn
Sep 30, 2025 32.90 Mn
Sep 30, 2025 32.90 Mn
Jun 30, 2025 -9.30 Mn
Jun 30, 2025 -9.30 Mn
Mar 31, 2025 -900,000.00
Mar 31, 2025 -900,000.00
Dec 31, 2024 93.38 Mn
Dec 31, 2024 93.38 Mn
Sep 30, 2024 -71,892.00
Sep 30, 2024 -71,892.00
Jun 30, 2024 1.82 Mn
Jun 30, 2024 1.82 Mn
Mar 31, 2024 -1.12 Mn
Mar 31, 2024 -1.12 Mn
Dec 31, 2023 3.30 Mn
Dec 31, 2023 3.30 Mn